Diabetes Trials in Moscow, Russia
Conditions / Diabetes / Moscow, Russia
Clinical trials for Diabetes investigate a range of treatment strategies and patient populations.
65 total trials for this combination
Showing top 10 of 65 trials
Trials
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT01179048 | Liraglutide Effect and Action in Diabetes: Evaluation of Cardiovascular Outcome Results | COMPLETED | PHASE3 |
| NCT03945968 | The Role of Concomitant Diseases in Postoperative Complications Risk Stratification. | RECRUITING | — |
| NCT02730377 | Efficacy in Controlling Glycaemia With Victoza® (Liraglutide) as add-on to Metformin vs. OADs as add-on to Metformin After up to 104 Weeks of Treatment in Subjects With Type 2 Diabetes | COMPLETED | PHASE4 |
| NCT01541215 | Efficacy and Safety of Liraglutide in Combination With Metformin Compared to Metformin Alone, in Children and Adolescents With Type 2 Diabetes | COMPLETED | PHASE3 |
| NCT04492384 | Analysis of Chronic Non-infectious Diseases Dynamics After COVID-19 Infection in Adult Patients | COMPLETED | — |
| NCT01959529 | A Trial Comparing Cardiovascular Safety of Insulin Degludec Versus Insulin Glargine in Subjects With Type 2 Diabetes at High Risk of Cardiovascular Events | COMPLETED | PHASE3 |
| NCT01336023 | Dual Action of Liraglutide and Insulin Degludec in Type 2 Diabetes: A Trial Comparing the Efficacy and Safety of Insulin Degludec/Liraglutide, Insulin Degludec and Liraglutide in Subjects With Type 2 Diabetes | COMPLETED | PHASE3 |
| NCT00882336 | European Study of Cardiovascular Risk | COMPLETED | — |
| NCT02607865 | Efficacy and Long-term Safety of Oral Semaglutide Versus Sitagliptin in Subjects With Type 2 Diabetes | COMPLETED | PHASE3 |
| NCT01720446 | Trial to Evaluate Cardiovascular and Other Long-term Outcomes With Semaglutide in Subjects With Type 2 Diabetes | COMPLETED | PHASE3 |